Prelude Therapeutics, Inc. (PRLD)
3.923
-0.18
(-4.32%)
USD |
NASDAQ |
Oct 30, 16:00
3.923
0.00 (0.00%)
After-Hours: 20:00
Prelude Therapeutics Cash and Short Term Investments (Annual) : 103.21M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 103.21M |
| December 31, 2024 | 133.61M |
| December 31, 2023 | 232.94M |
| December 31, 2022 | 201.73M |
| Date | Value |
|---|---|
| December 31, 2021 | 291.23M |
| December 31, 2020 | 218.31M |
| December 31, 2019 | 18.88M |
| December 31, 2018 | 15.60M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Q32 Bio, Inc. | 48.30M |
| Intellia Therapeutics, Inc. | 449.88M |
| Twist Bioscience Corp. | 232.43M |
| Beam Therapeutics, Inc. | 1.245B |
| Revolution Medicines, Inc. | 2.026B |